Answers are grounded in this paper and cite their sources.
Equine asthma is a disease which affects horses across the globe and can range from mild exercise impairment to severe debilitation that decreases the horse's quality of life. Treatment currently focuses on environmental management, bronchodilators and systemic and inhaled glucocorticosteroids. Glucocorticosteroids remain the mainstay of therapy but can have deleterious side effects; therefore, there is a critical need for the development of new therapies. Nebulised lidocaine and immunomodulatory therapy both hold promise for the treatment of equine asthma, especially with respect to avoiding the deleterious effects of glucocorticosteroids.
No takes yet. Share an insight, caveat, or question.
Lauren Holley (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: